Follow-up Study of Growth, Safety, and Efficacy of an Infant Formula for Healthy Term Infants
Launched by BYHEART · May 14, 2020
Trial Information
Current as of June 09, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Subjects who enrolled and completed the previous phase of the clinical trial: NCT04218929 "Evaluation of Growth, Safety, and Efficacy of an Infant Formula for Healthy Term Infants"
- Exclusion Criteria:
- • Subjects who did not enroll in the previous phase of the clinical trial: NCT04218929 "Evaluation of Growth, Safety, and Efficacy of an Infant Formula for Healthy Term Infants"
About Byheart
ByHeart is a pioneering nutrition company dedicated to transforming infant formula with a focus on quality, safety, and innovation. Committed to advancing infant health, ByHeart employs rigorous scientific research and clinical trials to develop products that meet the highest standards of nutritional excellence. With a mission to provide parents with trusted, evidence-based options, ByHeart leverages cutting-edge technology and a team of experts to ensure that their formulas are not only effective but also aligned with the latest advancements in pediatric nutrition. Through its commitment to transparency and consumer education, ByHeart aims to empower families in making informed choices for their children's health and well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Gainesville, Florida, United States
Jonesboro, Arkansas, United States
Layton, Utah, United States
Fairfield, Ohio, United States
Little Rock, Arkansas, United States
Cincinnati, Ohio, United States
Idaho Falls, Idaho, United States
Tucson, Arizona, United States
Charleston, South Carolina, United States
Zachary, Louisiana, United States
Houston, Texas, United States
Apopka, Florida, United States
Las Vegas, Nevada, United States
Plano, Texas, United States
Birmingham, Alabama, United States
Arcadia, California, United States
Sacramento, California, United States
Colorado Springs, Colorado, United States
Pensacola, Florida, United States
Tampa, Florida, United States
Dayton, Ohio, United States
Mentor, Ohio, United States
Summerville, South Carolina, United States
Bristol, Tennessee, United States
Jackson, Tennessee, United States
Kingsport, Tennessee, United States
Longview, Texas, United States
Patients applied
Trial Officials
Devon Kuehn, MD
Study Director
ByHeart, Inc.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials